SEC Filing Details
Document Details
Form
Filing Date
Feb 6, 2023
Document Date
Feb 2, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
CytomX Therapeutics, Inc.
Issuer
CytomX Therapeutics, Inc.
Filer
ROWLAND LLOYD A